CITIVIB P *CITICOLINE 500mg. IP + PIRACETAM 800mg. IP

Citivib P tablets combine Citicoline 500 mg and Piracetam 800 mg for supportive treatment of memory and cerebrovascular problems. Main uses: supportive treatment of cerebrovascular insufficiency (reduced blood flow to the brain in older patients); memory and concentration disturbances linked with cerebrovascular disease or ageing; supportive care after ischaemic stroke for recovery of brain function; supportive treatment of cognitive impairment after head injury; adjunctive treatment of age-related memory decline.

Common side effects of Citivib P Tablet include nausea; abdominal pain; loose motions; headache; dizziness; nervousness or restlessness. Get medical help at once if you notice severe allergic reaction with swelling of the face, lips or breathing difficulty; severe skin rash with blistering or peeling; unusual bleeding or worsening of bleeding in patients with haemorrhagic stroke.

Each Citivib P tablet contains Citicoline 500 mg + Piracetam 800 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Citivib P Tablet only as your doctor advises.

The MRP of Citivib P Tablet is ₹695 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹529.52 and the PTS is ₹476.57.

Each Citivib P tablet contains Citicoline 500 mg + Piracetam 800 mg. It comes in a pack of 10x10 (Alu Alu).

This combination works on two fronts in the brain. Citicoline provides the choline the body needs to repair nerve cell membranes and to build acetylcholine, the messenger chemical used in memory and thinking. Piracetam supports the working of nerve cells and helps keep memory, learning and attention functions active. Together they are intended to support brain function in patients with reduced blood supply to the brain or with memory and concentration problems linked with ageing, stroke or head injury.

Must not be used in patients who are allergic to piracetam or citicoline. Must not be used in patients with severe kidney disease. Must not be used in patients with Huntington's disease (Huntington's chorea). Must not be used in patients with ongoing bleeding inside the brain (haemorrhagic stroke). Check with a doctor first in pregnancy and breastfeeding.

Citivib P Tablet is a brand of Vibcare Pharma, sold through its Mind division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.